Tomaso Poggio - Twist Bioscience Non-Executive Independent Director
| 0ME Stock | EUR 28.55 1.18 4.31% |
Director
Dr. Tomaso A. Poggi is NonExecutive Independent Director of Mobileye N.V. He was Director of the Center for Brains, Minds, and Machines at the Massachusetts Institute of Technology . Since 2002, Professor Poggio was a professor at MIT in the Department of Brain Cognitive Sciences, Computer Science Artificial Intelligence Laboratory and the McGovern Institute for Brain Research. A former Corporationrationrate Fellow of Thinking Machines Corporationrationration, Professor Poggio was a director of PHZ Capital Partners, Inc. and was involved in starting, or investing in, several other hightech companies, including Arris Pharmaceutical Corporationration, DigitalPersona, Inc. and DeepMind. Professor Poggio holds a Ph.D in Theoretical Physics from the University of Genoa. since 2014.
| Age | 67 |
| Tenure | 10 years |
| Professional Marks | Ph.D |
| Phone | 800 719 0671 |
| Web | https://www.twistbioscience.com |
Twist Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.175) % which means that it has lost $0.175 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.312) %, meaning that it generated substantial loss on money invested by shareholders. Twist Bioscience's management efficiency ratios could be used to measure how well Twist Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.31 | |||
| Return On Asset | -0.17 |
Twist Bioscience Corp Leadership Team
Elected by the shareholders, the Twist Bioscience's board of directors comprises two types of representatives: Twist Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Twist. The board's role is to monitor Twist Bioscience's management team and ensure that shareholders' interests are well served. Twist Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Twist Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yonah Lloyd, Chief Communications Officer and Senior Vice President - Business Development | ||
| Gaby Hayon, Senior Vice President - Research & Development | ||
| Bill Peck, Chief Technology Officer | ||
| Pini Segal, Vice President - Finance & Human Resources | ||
| William Banyai, Senior Vice President of Research and Development, General Manager of Data Storage and Director | ||
| Eyal Desheh, Non-Executive Independent Director | ||
| Daniel Galves, Chief Communications Officer and Senior Vice-President | ||
| Robert Ragusa, Independent Director | ||
| Elad Serfaty, Vice President and General Manager of Aftermarket Division | ||
| Tal Babaioff, Vice President - Automotive Projects | ||
| Liz Yerushalmi, Vice President Legal Affairs | ||
| Eli Barkat, Non-Executive Independent Director | ||
| Patrick Weiss, Senior Vice President - Research & Development, General Manager - Data storage | ||
| Shai ShalevShwartz, Vice President - Technology | ||
| Martin Kunz, Senior Vice President - Operation | ||
| Judith Richter, Non-Executive Independent Director | ||
| Aaron Sato, Chief Scientific Officer, Biopharma and Vice President Protein Engineering | ||
| Shotaro Kawahara, CEO, Mobileye Japan Ltd | ||
| Jan Johannessen, Independent Director | ||
| Erin Smith, Senior Vice President - Government affairs and Public policy | ||
| Mark Daniels, Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer and Secretary | ||
| Itay Gat, Senior Vice President of Production Programs | ||
| Angela Bitting, Senior Vice President - Corporate Affairs | ||
| Elchanan Rushinek, Senior Vice President - Engineering | ||
| Ofer Maharshak, CFO, Senior Vice President | ||
| Gideon Stein, Chief Research Scientist | ||
| Keith Crandell, Independent Director | ||
| Robert Chess, Lead Independent Director | ||
| Frederick Craves, Independent Director | ||
| Yoram Gdalyahu, Vice President of Algorithms development | ||
| Emily Leproust, Chairman of the Board, President, Chief Executive Officer | ||
| Erez Dagan, Vice President of Advanced technology | ||
| Peter Neustadter, Non-Executive Independent Director and Presiding Director | ||
| Tomaso Poggio, Non-Executive Independent Director | ||
| Patrick Finn, Senior Vice President - Commercial operations | ||
| Nelson Chan, Independent Director | ||
| Kevin Yankton, VP Officer | ||
| Amnon Shashua, Chairman of the Board, Co-Founder, CTO, Executive Director | ||
| Ziv Aviram, President CEO, Co-Founder, Executive Director | ||
| Siyuan Chen, Chief Technology Officer | ||
| Dennis Cho, Gen VP | ||
| David Yoffie, Strategic Advisor | ||
| James Thorburn, Chief Financial Officer | ||
| Xiaoying Mai, Independent Director | ||
| Nicolas Barthelemy, Independent Director | ||
| Paula Green, Senior Vice President of Human Resources |
Twist Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Twist Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.31 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (0.99) % | |||
| Operating Margin | (1.10) % | |||
| Current Valuation | 1.03 B | |||
| Shares Outstanding | 56.86 M | |||
| Shares Owned By Insiders | 1.45 % | |||
| Shares Owned By Institutions | 98.55 % | |||
| Price To Book | 1.91 X | |||
| Price To Sales | 6.47 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |